REG - FTSE Russell Shire plc Hikma Pharmaceutical Apax Global Alpha Ld - Shire

Hikma PharmaceuticalsAnnouncement

19/12/2018 18:30

RNS Number : 0422L
FTSE Russell
19 December 2018
 



 



Further to the FTSE notice released on 18 December 2018 in relation to Takeda Pharmaceutical (Japan): Acquisition of Shire (UK), please note the replacement within the fixed index.
 
All other details remain unchanged. Please see updated notice below:
 



Takeda Pharmaceutical (Japan): Acquisition of Shire (UK)

Changes in FTSE UK Index Series

19 December 2018




Further to the FTSE Russell notice published on 14 December 2018, in relation to the acquisition of Shire (UK, constituent) by Takeda Pharmaceutical (Japan, non-constituent), please see details of affected indexes and effective dates below:
 
Shire (UK, B2QKY05) will be deleted from the FTSE 100 index.
 
Hikma Pharmaceuticals (UK, B0LCW08) will be added to the FTSE 100 Index and removed from the FTSE 250 Index.
 
Apax Global Alpha (UK, BWWYMV8) will be added to the FTSE 250 index.
 
All changes effective from 24 December 2018.
 
Full Index changes details available on FTSE Russell website.
 



 
 



For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:



Australia


+1800 653 680




Hong Kong


+852 2164 3333




Japan


+81 3 4563 6346




London


+44 (0) 20 7866 1810




New York


+1866 551 0617



                                   
 
Alternatively please visit our website at www.ftserussell.com
Terms of Use | Copyright © 2018 FTSE Russell



 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FTSGMMMZRLRGRZM